Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Affymax, Inc.
Affymax to Present at BIO CEO and Investor Conference
February 20th, 2009
Affymax, Inc. (Nasdaq:AFFY) announced that Arlene Morris, president and chief executive officer, will present at the 11th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2009, at 2:15 p.m. ET at the Waldorf Astoria in New York City. A live webcast of the presentation will be available on the investors section of the Company’s website at www.affymax.com. A replay will also be available for 30 days following the presentation. About Affymax, Inc. Affymax, Inc. is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax’s product candidate, Hematide™, is currently in Phase 3 clinical...
Source: Health Business Week (2009-02-20)
|
